Photoactivatable (alternatively, photoremovable, photoreleasable, or photocleavable)
protecting groups (PPGs), also known as caged or photocaged compounds, are used to …

Photodynamic therapy (PDT) is a promising treatment strategy where activation of
photosensitizer drugs with specific wavelengths of light results in energy transfer cascades …

The silicon phthalocyanine Pc 4 is a second-generation photosensitizer that has several
properties superior to other photosensitizers currently approved by the FDA, and it has …

The phthalocyanine photosensitizer Pc 4 has been shown to bind preferentially to
mitochondrial and endoplasmic reticulum membranes. Upon photoirradiation of Pc 4 …

In photodynamic therapy (PDT), the light activation of a photosensitizer leads to the
generation of reactive oxygen species that can trigger various mechanisms of cell death …

In this paper we describe a straightforward supramolecular strategy to encapsulate silicon
phthalocyanine (SiPc) photosensitizers (PS) in polymeric micelles made of poly (ε …

Currently, nanoscience is a major part of biomedical research, due to material advances that
aid the development of new tools and techniques to replace traditional methods. To this end …

The current clinical mainstays for cancer treatment, namely, surgical resection,
chemotherapy, and radiotherapy, can cause significant trauma, systemic toxicity, and …

Tissular oxygen concentration plays a key role during photodynamic therapy (PDT).
Therefore, monitoring its local oxygen partial pressure (pO 2) may help predict and/or control …

The use of macrocyclic molecules for both imaging and photodynamic therapy (PDT) has
proven to be a powerful method for assessing and treating diseases, respectively. However …